🇺🇸 FDA
Pipeline program

Kangdaprevir Sodium Tablet

PCD-DHEC84048-17-01

Phase 1 small_molecule completed

Quick answer

Kangdaprevir Sodium Tablet for Chronic Hepatitis c is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Chronic Hepatitis c
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials